Global Liver Disease Treatment Market
According to the report “ Liver Disease Treatment Market ", published by Market Data Forecast , the global market is projected to reach USD 17.25 billion with a CAGR of 11.72 % from USD 9.25 billion in 2016 .
Liver is a vital organ of the body performing umpteen complex functions such as fighting infections , removing toxins , bile secretion , and it produces clotting factors , proteins , and cholesterol , among others . Malfunctioning of liver can be life-threatening as it can cause multiple acute and chronic diseases ( hepatitis , non-alcoholic fatty liver disease , liver cancer , liver tumour , and liver cirrhosis , among others ). The initial symptoms of liver damage include nausea , fatigue , diarrhoea , jaundice , swollen abdomen , and mental disorientation among other . Acute liver damage can be treated through proper medication , if detected early , otherwise liver transplant is required . Liver damage can be prevented by adopting healthy lifestyle and practicing proper hygiene .
The growth of Liver Disease Treatment market is majorly driven by factors such as boost in Research & Development investment , unorganized lifestyle , rising public awareness , growth in geriatric population , and unmet needs for the treatment of liver cancer . Additionally , spur in demand for alcohol has increased the risk of liver cirrhosis . According to World Health Organization , alcohol consumption is anticipated to cause 20 % to 50 % of cirrhosis of the liver . Also , growing obese population has also increased the risk of non-alcoholic fatty liver disease which is caused by build-up of fat in the liver . The obese population has doubled since 1980 . In 2014 , approximately 13 % of the world ’ s population , that is , more than 600 million adults were obese as per World Health Organization .
The global Liver Disease Treatment Market is segmented on the basis of Treatment Modality and Disease Type
Based on Treatment Modality
� � � � � �
Antiviral Vaccines Chemotherapy Immunosuppressive Agents Corticosteroids Others
Based on Disease Type
� � � � �
Hepatitis Non-Alcoholic Fatty Liver Disease Alcohol Induced Liver Cancer Others
Geographical Segmentation :
� �
North America Europe
+ 1 888-702-9626 | www . marketdataforecast . com | contact @ marketdataforecast . com